Abstract
Often overshadowed by commercial interest in China and India, the countries of
SE Asia offer both a growing market for biopharmaceuticals and a
research-driven environment for their development.
The worldwide market for biotechnology pharmaceuticals was valued by Espicom
at an estimated US$80 billion in 2007, representing 9.6% of the total global
pharmaceutical sales (prescription and OTC), which stood at approximately
US$830 billion. In 2007, reported sales of 40 of the leading
biopharmaceuticals sold by the major western manufacturers totalled US$71.6
billion, having risen by 13.7% over the previous year.
This detailed report analyses the market and research environments, assessing
risk and identifying opportunity in Indonesia, Malaysia, Singapore, South
Korea, Taiwan and Thailand.
Providing......
- A thorough review of the burgeoning market for biopharmaceutical drugs in
SE Asia
- An examination of the markets in terms of investment and research
opportunities
- Market forecasts to 2013 for biopharmaceuticals
- A review of over 65 local companies/ organisations developing
biopharmaceutical products
Markets covered......
- Indonesia
- Malaysia
- Singapore
- South Korea
- Taiwan
- Thailand
View Cart
